Prosight Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001617201

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2025 · 42 positions · Total reported value $428.78M · Top-10 concentration 55.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.6% · 9 new · 12 cut · 13 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -1.1% · vs SPY -3.2% · Prev Value $580.35M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -6.1% · vs SPY -8.3% · Latest Value $515.48M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, Prosight Management, LP disclosed 42 equity positions with a combined reported value of $428.78M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 55.8% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were LKFT ($39.84M), MGTX ($33.66M), ADCT ($29.89M). By sector, the heaviest allocations are Health Care 81.2%, Consumer Discretionary 0.1%. Versus the prior quarter, allocation shifted toward Health Care (+2.1pp) and away from Other (-2.2pp).

Versus the prior quarter, Prosight Management, LP opened 9 new positions, trimmed 12 and fully exited 13, a turnover rate of 75.6% of positions. The portfolio's overlap with the prior quarter was 62% of names.

The largest new positions opened in Q3 2025 were ISRG ($21.79M), CORT ($12.28M), VRTX ($8.03M).

Of the 13 positions fully exited versus the prior quarter, the largest were UNH ($34.32M), MIRM ($10.18M), LIVN ($6.30M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • ISRG INTUITIVE SURGICAL INC · $21.79M
  • CORT CORCEPT THERAPEUTICS INC · $12.28M
  • VRTX VERTEX PHARMACEUTICALS INC · $8.03M
  • BSX BOSTON SCIENTIFIC CORP · $7.43M
  • PRCT PROCEPT BIOROBOTICS CORP · $2.75M
  • ALGN ALIGN TECHNOLOGY INC · $2.43M
  • TWST TWIST BIOSCIENCE CORP · $2.11M
  • AKRO AKERO THERAPEUTICS INC · $1.86M

Fully Exited (vs previous quarter)

  • UNH UNITEDHEALTH GROUP INC · prev qtr: $34.32M
  • MIRM MIRUM PHARMACEUTICALS INC · prev qtr: $10.18M
  • LIVN LIVANOVA PLC · prev qtr: $6.30M
  • AXGN AXOGEN INC · prev qtr: $3.07M
  • LNTH LANTHEUS HLDGS INC · prev qtr: $2.83M
  • MURA MURAL ONCOLOGY PUB LTD CO · prev qtr: $2.22M
  • ERAS ERASCA INC · prev qtr: $305.18K
  • PEPG PEPGEN INC · prev qtr: $270.82K

Insider Transactions (Form 4)

Latest Prosight Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Prosight Management, LP is an SEC-registered 13F filer based in Dallas, TX, United States. As of Q2 2026 it reported 36 US equity positions with a combined value of $580.35M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: DALLAS, TX, United States
  • SEC registration: 801-108047 (status: Approved), registered 2016-07-01
  • Regulatory AUM (Form ADV): $1.04B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: prosightcapital.com

Portfolio Structure

  • 36 positions · $580.35M reported value (Q2 2026)
  • Top 10 holdings = 70.7% of reported value
  • Largest position: LKFT (LAKEFRONT BIOTHERAPEUTICS NV) at 10.6%
  • Average position size: $16.12M

Sector Tilt

  • Health Care 83.6%
  • Information Technology 3.2%
  • (classified holdings cover 87% of value)

Quarterly Activity

  • Q2 2026: 5 new, 16 added, 15 reduced, 15 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 81.2%
Other 18.7%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.15M $39.84M 9.29%
9.29%
Reduce
2 4.09M $33.66M 7.85%
7.85%
Reduce
3 7.47M $29.89M 6.97%
6.97%
Reduce
4 2.76M $24.41M 5.69%
5.69%
Reduce
5 48.71K $21.79M 5.08%
5.08%
New
6 865.35K $21.15M 4.93%
4.93%
Add
7 1.34M $20.21M 4.71%
4.71%
Reduce
8 109.50K $19.16M 4.47%
4.47%
Add
9 1.00M $15.44M 3.60%
3.60%
Reduce
10 264.50K $13.74M 3.20%
3.20%
Reduce
11 328.68K $13.69M 3.19%
3.19%
Add
12 1.71M $13.47M 3.14%
3.14%
Reduce
13 195.22K $13.14M 3.06%
3.06%
Add
14 5.45M $13.03M 3.04%
3.04%
Reduce
15 749.61K $12.80M 2.99%
2.99%
Reduce
16 610.00K $12.77M 2.98%
2.98%
Add
17 147.80K $12.28M 2.87%
2.87%
New
18 698.47K $11.26M 2.63%
2.63%
Add
19 874.91K $11.23M 2.62%
2.62%
Add
20 600.00K $9.01M 2.10%
2.10%
Add
21 20.50K $8.03M 1.87%
1.87%
New
22 76.10K $7.43M 1.73%
1.73%
New
23 504.03K $7.33M 1.71%
1.71%
Add
24 250.00K $6.19M 1.44%
1.44%
Add
25 379.25K $5.95M 1.39%
1.39%
Reduce
26 308.71K $5.72M 1.33%
1.33%
Add
27 343.40K $4.34M 1.01%
1.01%
Reduce
28 1.27M $4.13M 0.96%
0.96%
Reduce
29 76.99K $2.75M 0.64%
0.64%
New
30 19.44K $2.43M 0.57%
0.57%
New
31 3.30K $2.43M 0.57%
0.57%
Reduce
32 75.00K $2.11M 0.49%
0.49%
New
33 39.07K $1.86M 0.43%
0.43%
New
34 564.80K $1.80M 0.42%
0.42%
Reduce
35 439.94K $1.51M 0.35%
0.35%
Reduce
36 267.96K $736.89K 0.17%
0.17%
Add
37 34.83K $698.69K 0.16%
0.16%
New
38 567.90K $650.24K 0.15%
0.15%
Add
39 79.48K $487.19K 0.11%
0.11%
New
40 20.00K $195.20K 0.05%
0.05%
Reduce
41 20.49K $30.32K 0.01%
0.01%
Reduce
42 885 $5.92K 0.00%
0.00%
New

FAQ

What did Prosight Management, LP buy in 2025-Q3?

In its 2025-Q3 13F filing, Prosight Management, LP reported 42 equity positions worth $428.78M in aggregate; its largest disclosed positions were LKFT ($39.84M), MGTX ($33.66M), ADCT ($29.89M).

How large is Prosight Management, LP's portfolio?

Prosight Management, LP reported $428.78M of long equity holdings across 42 positions as of 2025-Q3. Top-10 holdings account for 55.8% of reported value.

What is Prosight Management, LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/prosight-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →